The science of when you should exercise to beat obesity

A new paper in Obesity explores the diurnal relationship of obesity to MVPA – at what time does MVPA pay off the most in preventing obesity?

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for Antibody Discovery at Rapid Novor.

August 23, 2023

Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation – Biotech Investments

EQS-News: Volta Medical SAS / Key word(s): Miscellaneous Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation

May 10, 2024

Novo Nordisk continues to stack obesity pipeline, this time with Swiss zebrafish biotech

Novo Nordisk licensed an experimental obesity pill from EraCal Therapeutics in a deal worth €235 million, or roughly $255 million, as it hunts for the

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.